Oscar Health Inc 's Revenue in the fiscal year 2025 $ 11,701.43 millions
Oscar Health Inc 's Revenue in the fiscal year 2024 $ 9,177.56 millions
Oscar Health Inc 's Revenue in the fiscal year 2023 $ 5,862.87 millions
Oscar Health Inc 's Revenue in the fiscal year 2022 $ 3,963.64 millions
Oscar Health Inc 's Revenue in the fiscal year 2021 $ 1,838.72 millions
OSCR Revenue second quarter 2026 Y/Y Growth Comment
Oscar Health Inc reported Revenue surge of 70.4% year on year in the second quarter 2026, to $ 4,880.22 millions, this is lower than Oscar Health Inc 's recent average Revenue surge of 107.24%.
According to the results reported in the second quarter 2026, Oscar Health Inc achieved the best Revenue growth in Accident & Health Insurance industry. While Oscar Health Inc ' s Revenue jump of 70.4% ranks overall at the positon no. 354 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Oscar Health Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
134.27 %
21.7 %
-16.12 %
(Mar 31 2021)
OSCR's II. Quarter Q/Q Revenue Comment
Oscar Health Inc achieved in the II. Quarter 2026 below company average Revenue increase of 5.01% quarter on quarter, to $ 4,880.22 millions.
II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -5.98% in the II. Quarter a year ago.
Within Accident & Health Insurance industry 3 other companies have achieved higher Revenue quarter on quarter growth. While Oscar Health Inc 's Revenue growth quarter on quarter, overall rank is 1095.
Oscar Health Inc achieved in the II. Quarter 2026 below company average Revenue increase of 5.01% quarter on quarter, to $ 4,880.22 millions.
II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -5.98% in the II. Quarter a year ago.
Within Accident & Health Insurance industry 3 other companies have achieved higher Revenue quarter on quarter growth. While Oscar Health Inc 's Revenue growth quarter on quarter, overall rank is 1095.
Oscar Health Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 15,318.63
$ 13,302.36
$ 11,701.43
$ 11,288.63
$ 10,726.13
Y / Y Revenue Growth (TTM)
42.82 %
31.95 %
27.5 %
37.38 %
48.29 %
Year on Year Revenue Growth Overall
Ranking
# 314
# 238
# 30
# 131
# 244
Seqeuential Revenue Change (TTM)
15.16 %
13.68 %
3.66 %
5.24 %
6.39 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 1798
# 1227
# 238
# 619
# 1026
Cumulative Revenue growth Comment
Although Oscar Health Inc 's Annual Revenue growth year on year were below company's average 54.3% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 42.82% year on year, from 31.95% in Mar 31 2026.
In the Financial sector 55 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 238 to 314.
Although Oscar Health Inc 's Annual Revenue growth year on year were below company's average 54.3% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 42.82% year on year, from 31.95% in Mar 31 2026.
In the Financial sector 55 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 238 to 314.
About Oscar Health Inc Revenue Growth Rates (OSCR), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.